Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / OrganismsTools
SugarDrawer
GlycanBuilder
Glycan Converters
GlycoMaple
GlycomeAtlas
LM-GlycomeAtlas
GALAXY
MCAW
GlycoSim
GRable
Guidelines
MIRAGE
G48488CO
Summary
- GlyTouCan ID
-
G48488CO
- Subsumption Level
- Monosaccharide composition
- Monoisotopic Mass
- 3755.33
3D Structures
- GlycoShape
- G48488CO
Organisms
| Organisms | Evidence |
|---|---|
| Homo sapiens (human) |
Taxonomic Hierarchy
Core Protein
| UniProt ID | Protein Name | Reference | Source |
|---|---|---|---|
| P01588 | Erythropoietin | ||
| P07911 | Uromodulin | ||
| P08637 | Low affinity immunoglobulin gamma Fc region receptor III-A | ||
| P41222 | Prostaglandin-H2 D-isomerase | ||
| P98119 | Salivary plasminogen activator alpha 1 |
Sequence Descriptors
- GlycoCT
-
RES 1b:x-HEX-1:5 2s:n-acetyl 3b:x-HEX-1:5 4s:n-acetyl 5b:x-HEX-1:5 6s:n-acetyl 7b:x-HEX-1:5 8s:n-acetyl 9b:x-HEX-1:5 10s:n-acetyl 11b:x-HEX-1:5 12s:n-acetyl 13b:x-HEX-1:5 14s:n-acetyl 15b:x-dgro-dgal-NON-2:6|1:a|2:keto|3:d 16s:n-acetyl 17b:x-dgro-dgal-NON-2:6|1:a|2:keto|3:d 18s:n-acetyl 19b:x-dgro-dgal-NON-2:6|1:a|2:keto|3:d 20s:n-acetyl 21b:x-HEX-1:5 22b:x-HEX-1:5 23b:x-HEX-1:5 24b:x-HEX-1:5 25b:x-HEX-1:5 26b:x-HEX-1:5 27b:x-HEX-1:5 28b:x-HEX-1:5 29b:x-HEX-1:5|6:d LIN 1:1d(2+1)2n 2:3d(2+1)4n 3:5d(2+1)6n 4:7d(2+1)8n 5:9d(2+1)10n 6:11d(2+1)12n 7:13d(2+1)14n 8:15d(5+1)16n 9:17d(5+1)18n 10:19d(5+1)20n
- WURCS
- WURCS=2.0/4,19,18/[Aad21122h-2x_2-6_5*NCC/3=O][axxxxm-1x_1-5][axxxxh-1x_1-5_2*NCC/3=O][axxxxh-1x_1-5]/1-1-1-2-3-3-3-3-3-3-3-4-4-4-4-4-4-4-4/a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?_a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?}-{a?|b?|c?|d?|e?|f?|g?|h?|i?|j?|k?|l?|m?|n?|o?|p?|q?|r?|s?
Literature
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 33737529 | Toward robust N-glycomics of various tissue samples that may contain glycans with unknown or unexpected structures | Suzuki Noriko | 2021-03-18 |
|
| 33383989 | Bisecting GlcNAc Protein N-Glycosylation Is Characteristic of Human Adipogenesis | Wongtrakul-Kish K | 2021 Feb 5 |
|
| 32578997 | Cysteine Aminoethylation Enables the Site-Specific Glycosylation Analysis of Recombinant Human Erythropoietin using Trypsin | Lippold S | 2020 Jul 21 |
|
| 31467031 | Primary Human Natural Killer Cells Retain Proinflammatory IgG1 at the Cell Surface and Express CD16a Glycoforms with Donor-dependent Variability | Patel KR | 2019 Nov |
|
| 30237853 | Distinct urinary glycoprotein signatures in prostate cancer patients | Kawahara R | 2018 Sep 4 |
|
| 7737204 | Structural Analysis of the Sialylated N- and O-Linked Carbohydrate Chains of Recombinant Human Erythropoietin Expressed in Chinese Hamster Ovary Cells. Sialylation Patterns and Branch Location of Dimeric N-acetyllactosamine Units | Hokke CH | 1995 Mar 15 |
|
| 7527189 | A Strategy for the Mapping of N-Glycans by High-Performance Capillary Electrophoresis | Hermentin P | 1994 Aug 15 |
|
| 8477709 | Structures of sialylated oligosaccharides of human erythropoietin expressed in recombinant BHK-21 cells | NIMTZ M | 1993 Apr 01 |
|
| 1443598 | Quantitative mapping of the N-linked sialyloligosaccharides of recombinant erythropoietin: Combination of direct high-performance anion-exchange chromatography and 2-aminopyridine derivatization | Rice KG | 1992 Nov 01 |
|
